Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_provenance.
- NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_assertion description "[Gene mutations of KIT or PDGFRA are critical in GISTs, because the aberrant versions not only are correlated with the specific cell morphology, histologic phenotype, metastasis, and prognosis, but also are the targets of therapy with imatinib and other agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_provenance.
- NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_assertion evidence source_evidence_literature NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_provenance.
- NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_assertion SIO_000772 18671247 NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_provenance.
- NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_assertion wasDerivedFrom befree-20140225 NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_provenance.
- NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_assertion wasGeneratedBy ECO_0000203 NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_provenance.